Streetbeat News

Analyst Ratings

HAIN

Hain Celestial Group (NASDAQ:HAIN) reported Q1 adjusted losses of $(0.04) per share, beating the analyst consensus estimate of $(0.06) by 33.33%. However, the company's quarterly sales of $425.03M missed the analyst consensus estimate of $431.32M by 1.46%. This represents a 140% decrease in earnings and a 3.26% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:22 pm

VTR

Wedbush analyst Richard Anderson has upgraded Ventas (NYSE:VTR) from Neutral to Outperform and raised the price target from $44 to $51.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:20 pm

DOCN

Goldman Sachs analyst Gabriela Borges has upgraded DigitalOcean Holdings (NYSE:DOCN) from Sell to Buy and announced a $33 price target.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:18 pm

TRDA

Entrada Therapeutics reported Q3 earnings of $1.02 per share, beating the analyst consensus estimate of $(0.74) by 237.84 percent. This is a 227.5 percent increase over losses of $(0.80) per share from the same period last year. The company also reported quarterly sales of $43.73 million, beating the analyst consensus estimate of $9.60 million by 355.57 percent.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:16 pm

PMTS

CPI Card (NASDAQ:PMTS) reported Q3 earnings of $0.33 per share, missing the analyst consensus estimate of $0.49 by 32.65%. This is a 67.33% decrease from the same period last year. The company also reported quarterly sales of $105.86 million, missing the analyst consensus estimate of $113.85 million by 7.02%. This is a 15.02% decrease from the same period last year.

Portfolio Pulse from mahesh@benzinga.com

November 07, 2023 | 12:06 pm

BLUE

bluebird bio (NASDAQ:BLUE) reported Q3 losses of $(0.66) per share, beating the analyst consensus estimate of $(0.67) by 1.49 percent. This is a 29.79 percent increase over losses from the same period last year. However, the company's quarterly sales of $12.39 million missed the analyst consensus estimate of $13.31 million by 6.90 percent.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:05 pm

MASS

908 Devices reported Q3 losses of $(0.22) per share, beating the analyst consensus estimate of $(0.30) by 26.67%. The company also reported quarterly sales of $14.30 million, surpassing the analyst consensus estimate of $13.45 million by 6.30%. However, both figures represent a decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:04 pm

BSY

Bentley Systems (NASDAQ:BSY) reported Q3 earnings of $0.22 per share, beating the analyst consensus estimate of $0.19 by 15.79%. The company also reported quarterly sales of $306.61 million, surpassing the analyst consensus estimate of $299.91 million by 2.23%. Both earnings and sales have increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:03 pm

LCII

LCI Indus (NYSE:LCII) reported Q3 earnings of $1.02 per share, missing the analyst consensus estimate of $1.49 by 31.54 percent. This is a 57.5 percent decrease from the same period last year. The company's quarterly sales of $1.00 billion met the analyst consensus estimate, marking an 11.66 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:03 pm

GFS

GLOBALFOUNDRIES (NASDAQ:GFS) reported Q3 earnings of $0.55 per share, beating the analyst consensus estimate of $0.49 by 12.24%. However, this is a 17.91% decrease from the same period last year. The company also reported quarterly sales of $1.85 billion, slightly beating the estimate of $1.85 billion by 0.11%, but this is a 10.70% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:01 pm